Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Blog June 7, 2018
Pfizer and Merck's Steglatro for type 2 diabetes: a valuable addition to the rapidly rising SGLT-2 inhibitor market
Digital Medicine: The Connection Between Pharma and Medical Devices Digital Medicine: The Connection Between Pharma and Medical Devices
Blog May 30, 2018
Digital Medicine: The Connection Between Pharma and Medical Devices
Blog May 21, 2018
WhatsApp could prove a powerful patient engagement tool for pharma
Blog May 14, 2018
9 Ways Payers May be Impacted by Vertical Integration
Blog May 11, 2018
IDNs’ Continued Displacement of Traditional Insurers
Blog May 2, 2018
Novo Nordisk’s Ozempic: Launch was late but sales forecasts climbing
Blog May 1, 2018
Algeria, Morocco and Tunisia changing their regulatory landscape?
Blog April 18, 2018
GSK's Shingrix set to become the market leading shingles vaccine
Blog March 27, 2018
The opioid crisis: a 21st century pain
Blog March 9, 2018
With Cigna–Express Scripts, last PBM domino falls